Search Within

Jinrong Qu

Formats
  1. Meeting Abstract (10)
  2. Journal Article (6)
Groups
  1. Department of Medicine (16)
  2. Hematologic Malignancies, Division of (16)
  3. Center for Hematologic Malignancies (15)
  4. GSK Faculty (15)
  5. Hematologic Malignancies Research (15)
  6. Molecular Pharmacology and Chemistry Program Faculty (14)

More Groups

People
  1. Isabelle Riviere (16)
  2. Xiuyan Wang (16)
  3. Michel Sadelain (14)
  4. Teresa Wasielewska (11)
  5. Jolanta Stefanski (10)
  6. Oriana Borquez-Ojeda (10)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2016 (1)
  4. 2015 (3)
  5. 2014 (3)
  6. 2013 (5)

More Years

Publications
  1. Blood (4)
  2. Molecular Therapy (4)
  3. Human Gene Therapy (2)
  4. Science Translational Medicine (2)
  5. Journal of Clinical Oncology (1)
  6. Journal of Immunotherapy (1)

More Publications

Publishers
  1. Nature Publishing Group (6)
  2. American Society of Hematology (4)
  3. American Association for the Advancement of Science (2)
  4. Mary Ann Liebert, Inc (2)
  5. American Society of Clinical Oncology (1)
  6. Lippincott Williams & Wilkins (1)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: A phase 1 trial
    Journal Article

    Boulad, F.; Maggio, A.; Wang, X.; Moi, P.; Acuto, S.; Kogel, F.; Takpradit, C.; Prockop, S.; Mansilla-Soto, J.; Cabriolu, A.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Depletion of high-content CD14(+) cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing
    Journal Article

    Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Du, F.; Qu, J.; Chaudhari, J.; Thummar, K.; Zhu, M.; Shen, L. B.; Hall, M.; more...
    Molecular Therapy - Methods & Clinical Development (2021)

    Fulltext@MSK | Save
  • Evaluation of Miltenyi ExpAct and TransAct CD3/28 beads for CAR-T cell manufacturing
    Meeting Abstract

    Wang, X.; Qu, J.; Stefanski, J.; Borquez-Ojeda, O.; Hack, A.; He, Q.; Wasielewska, T.; Du, F.; Sadelain, M.; Rivière, I.
    Molecular Therapy (2016)

    Fulltext@MSK | Save
  • Comparison of CTS™ Dynabeads® CD3/CD28, Miltenyi TransAct CD3/28 and ExpAct Beads for large-scale CAR T cell manufacturing
    Meeting Abstract

    Wang, X.; Stefanski, J.; Borquez-Ojeda, O.; Qu, J.; Hack, A.; He, Q.; Wasielewska, T.; Du, F.; Sadelain, M.; Riviere, I.
    Human Gene Therapy (2015)

    Fulltext@MSK | Save
  • Depletion of high-content CD14+cells from apheresis products is critical for the successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing
    Meeting Abstract

    Wang, X. Y.; Qu, J. R.; Stefanski, J.; Du, F.; Borquez-Ojeda, O.; Hack, A.; Riviere, I.
    Molecular Therapy (2015)

    Fulltext@MSK | Save
  • Large-scale clinical-grade retroviral vector production in a fixed-bed bioreactor
    Journal Article

    Wang, X.; Olszewska, M.; Qu, J.; Wasielewska, T.; Bartido, S.; Hermetet, G.; Sadelain, M.; Rivière, I.
    Journal of Immunotherapy (2015)

    Fulltext@MSK | Save
  • Large-scale clinical grade retroviral vector production using a fixed-bed bioreactor
    Meeting Abstract

    Wang, X. Y.; Olszewska, M.; Qu, J. R.; Wasielewska, T.; Hermetet, G.; Sadelain, M.; Riviere, I.
    Human Gene Therapy (2014)

    Fulltext@MSK | Save
  • Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation
    Journal Article

    Boulad, F.; Wang, X.; Qu, J.; Taylor, C.; Ferro, L.; Karponi, G.; Bartido, S.; Giardina, P.; Heller, G.; Prockop, S. E.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Journal Article

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Park, J.; Curran, K.; Chung, S. S.; Stefanski, J.; Borquez-Ojeda, O.; Olszewska, M.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL
    Meeting Abstract

    Park, J. H.; Rivière, I.; Wang, X.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Wasielewska, T.; Taylor, C.; Qu, J.; Bartido, S.; more...
    Blood (2013)

    Fulltext@MSK | Save